DOI QR코드

DOI QR Code

A Risk Prediction Model for Operative Mortality after Heart Valve Surgery in a Korean Cohort

  • Kim, Ho Jin (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Joon Bum (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Seon-Ok (Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Yun, Sung-Cheol (Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Lee, Sak (Department of Thoracic and Cardiovascular Surgery, Severance Hospital, Yonsei University College of Medicine) ;
  • Lim, Cheong (Department of Thoracic and Cardiovascular Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine) ;
  • Choi, Jae Woong (Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine) ;
  • Hwang, Ho Young (Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine) ;
  • Kim, Kyung Hwan (Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine) ;
  • Lee, Seung Hyun (Department of Thoracic and Cardiovascular Surgery, Severance Hospital, Yonsei University College of Medicine) ;
  • Yoo, Jae Suk (Department of Cardiovascular Surgery, Sejong General Hospital) ;
  • Sung, Kiick (Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Je, Hyung Gon (Department of Thoracic and Cardiovascular Surgery, Pusan National University Yangsan Hospital) ;
  • Hong, Soon Chang (Department of Thoracic and Cardiovascular Surgery, Wonju Severance Christian Hospital) ;
  • Kim, Yun Jung (National Evidence-based Healthcare Collaborating Agency) ;
  • Kim, Sung-Hyun (National Evidence-based Healthcare Collaborating Agency) ;
  • Chang, Byung-Chul (Department of Thoracic and Cardiovascular Surgery, CHA Bundang Medical Center, CHA University School of Medicine)
  • Received : 2020.07.28
  • Accepted : 2020.09.09
  • Published : 2021.04.05

Abstract

Background: This study aimed to develop a new risk prediction model for operative mortality in a Korean cohort undergoing heart valve surgery using the Korea Heart Valve Surgery Registry (KHVSR) database. Methods: We analyzed data from 4,742 patients registered in the KHVSR who underwent heart valve surgery at 9 institutions between 2017 and 2018. A risk prediction model was developed for operative mortality, defined as death within 30 days after surgery or during the same hospitalization. A statistical model was generated with a scoring system by multiple logistic regression analyses. The performance of the model was evaluated by its discrimination and calibration abilities. Results: Operative mortality occurred in 142 patients. The final regression models identified 13 risk variables. The risk prediction model showed good discrimination, with a c-statistic of 0.805 and calibration with Hosmer-Lemeshow goodness-of-fit p-value of 0.630. The risk scores ranged from -1 to 15, and were associated with an increase in predicted mortality. The predicted mortality across the risk scores ranged from 0.3% to 80.6%. Conclusion: This risk prediction model using a scoring system specific to heart valve surgery was developed from the KHVSR database. The risk prediction model showed that operative mortality could be predicted well in a Korean cohort.

Keywords

References

  1. Statistics Korea. Cause of death in 2018 [Internet]. Daejeon: Statistics Korea; 2018 [cited 2020 Jul 13] Available from: http://kostat.go.kr/wnsearch/search.jsp.
  2. Kim MS, Cho SJ, Park SJ, et al. Frequency and clinical associating factors of valvular heart disease in asymptomatic Korean adults. Sci Rep 2019;9:16741. https://doi.org/10.1038/s41598-019-53277-0
  3. Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med 2019;380:1695-705. https://doi.org/10.1056/NEJMoa1814052
  4. Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med 2019;380:1706-15. https://doi.org/10.1056/NEJMoa1816885
  5. Kim DH, Kang DH. Early surgery in valvular heart disease. Korean Circ J 2018;48:964-73. https://doi.org/10.4070/kcj.2018.0308
  6. Park SJ, Kim DJ, Kim JB, Park KH, Lee JW. Cardiothoracic surgery training in South Korea: challenges and new hopes. J Thorac Cardiovasc Surg 2019;159:205-14.
  7. Nashef SA, Roques F, Sharples LD, et al. EuroSCORE II. Eur J Cardiothorac Surg 2012;41:734-44. https://doi.org/10.1093/ejcts/ezs043
  8. D'Agostino RS, Jacobs JP, Badhwar V, et al. The Society of Thoracic Surgeons Adult Cardiac Surgery Database: 2018 update on outcomes and quality. Ann Thorac Surg 2018;105:15-23. https://doi.org/10.1016/j.athoracsur.2017.10.035
  9. Miyata H, Tomotaki A, Motomura N, Takamoto S. Operative mortality and complication risk model for all major cardiovascular operations in Japan. Ann Thorac Surg 2015;99:130-9. https://doi.org/10.1016/j.athoracsur.2014.07.038
  10. Billah B, Reid CM, Shardey GC, Smith JA. A preoperative risk prediction model for 30-day mortality following cardiac surgery in an Australian cohort. Eur J Cardiothorac Surg 2010;37:1086-92. https://doi.org/10.1016/j.ejcts.2009.11.021
  11. Heinze G, Wallisch C, Dunkler D. Variable selection: a review and recommendations for the practicing statistician. Biom J 2018;60:431-49. https://doi.org/10.1002/bimj.201700067
  12. Moons KG, Kengne AP, Woodward M, et al. Risk prediction models: I. development, internal validation, and assessing the incremental value of a new (bio)marker. Heart 2012;98:683-90. https://doi.org/10.1136/heartjnl-2011-301246
  13. Moons KG, Kengne AP, Grobbee DE, et al. Risk prediction models: II. external validation, model updating, and impact assessment. Heart 2012;98:691-8. https://doi.org/10.1136/heartjnl-2011-301247
  14. Loor G, Koch CG, Sabik JF 3rd, Li L, Blackstone EH. Implications and management of anemia in cardiac surgery: current state of knowledge. J Thorac Cardiovasc Surg 2012;144:538-46. https://doi.org/10.1016/j.jtcvs.2012.04.014
  15. Mariscalco G, Wozniak MJ, Dawson AG, et al. Body mass index and mortality among adults undergoing cardiac surgery: a nationwide study with a systematic review and meta-analysis. Circulation 2017;135:850-63. https://doi.org/10.1161/CIRCULATIONAHA.116.022840
  16. Eckardt KU, Berns JS, Rocco MV, Kasiske BL. Definition and classification of CKD: the debate should be about patient prognosis: a position statement from KDOQI and KDIGO. Am J Kidney Dis 2009;53:915-20. https://doi.org/10.1053/j.ajkd.2009.04.001
  17. Patrat-Delon S, Rouxel A, Gacouin A, et al. EuroSCORE II underestimates mortality after cardiac surgery for infective endocarditis. Eur J Cardiothorac Surg 2016;49:944-51. https://doi.org/10.1093/ejcts/ezv223
  18. LaPar DJ, Likosky DS, Zhang M, et al. Development of a risk prediction model and clinical risk score for isolated tricuspid valve surgery. Ann Thorac Surg 2018;106:129-36. https://doi.org/10.1016/j.athoracsur.2017.11.077
  19. Grant SW, Hickey GL, Dimarakis I, et al. How does EuroSCORE II perform in UK cardiac surgery: an analysis of 23 740 patients from the Society for Cardiothoracic Surgery in Great Britain and Ireland National Database. Heart 2012;98:1568-72. https://doi.org/10.1136/heartjnl-2012-302483
  20. Singh N, Gimpel D, Parkinson G, et al. Assessment of the EuroSCORE II in a New Zealand tertiary centre. Heart Lung Circ 2019;28:1670-6. https://doi.org/10.1016/j.hlc.2018.09.004
  21. Casalino R, Tarasoutchi F, Spina G, et al. EuroSCORE models in a cohort of patients with valvular heart disease and a high prevalence of rheumatic fever submitted to surgical procedures. PLoS One 2015;10:e0118357. https://doi.org/10.1371/journal.pone.0118357
  22. Kang DH, Park SJ, Lee SA, et al. Early surgery or conservative care for asymptomatic aortic stenosis. N Engl J Med 2020;382:111-9. https://doi.org/10.1056/NEJMoa1912846
  23. Kim WK, Kim HJ, Kim JB, et al. Clinical outcomes in 1731 patients undergoing mitral valve surgery for rheumatic valve disease. Heart 2018;104:841-8. https://doi.org/10.1136/heartjnl-2017-312249
  24. Lee H, Lee KS, Sim SB, Jeong HS, Ahn HM, Chee HK. Trends in percutaneous coronary intervention and coronary artery bypass surgery in Korea. Korean J Thorac Cardiovasc Surg 2016;49(Suppl 1):S60-7.
  25. Marwick TH, Amann K, Bangalore S, et al. Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int 2019;96:836-49. https://doi.org/10.1016/j.kint.2019.06.025
  26. Idrees JJ, Roselli EE, Blackstone EH, et al. Risk of adding prophylactic aorta replacement to a cardiac operation. J Thorac Cardiovasc Surg 2020;159:1669-78. https://doi.org/10.1016/j.jtcvs.2019.05.001
  27. Ad N, Damiano RJ Jr, Badhwar V, et al. Expert consensus guidelines: examining surgical ablation for atrial fibrillation. J Thorac Cardiovasc Surg 2017;153:1330-54. https://doi.org/10.1016/j.jtcvs.2017.02.027
  28. Badhwar V, Rankin JS, Damiano RJ Jr, et al. The Society of Thoracic Surgeons 2017 clinical practice guidelines for the surgical treatment of atrial fibrillation. Ann Thorac Surg 2017;103:329-41. https://doi.org/10.1016/j.athoracsur.2016.10.076
  29. The Korea Heart Foundation. Cardiac surgery annual report [Internet]. Seoul: The Korea Heart Foundation; 2018-2019 [cited 2020 Sep 6] Available from: https://www.heart.or.kr/Home/reference.